One name looms largest when it comes to vehicle air bag recalls.
Most of our readers likely surmise that global medical device and consumer-goods manufacturer Johnson & Johnson has deep pockets when it comes to litigation outlays.
The verbal sparring persists regarding mobile insulin pumps used by high numbers of U.S. consumers. Legions of those individuals are children. Reportedly, about 250,000 adolescents across the country use pumps manufactured by Medtronic Inc., the leading device maker.
Admit it. Even as an adult, you’ve probably been challenged a time or two when dealing with those flimsy plastic or Styrofoam containers that brim with geyser-like hot water and steaming instant noodles.
If what just happened in a California courtroom is a sign of things to come, executives from the agricultural company Monsanto (acquired recently by pharmaceutical giant Bayer) are sweating proverbial bullets.
There’s kind of a flip side -- both stark and dramatic -- to every stated upside concerning Bayer’s longtime industry-leading birth control implant Essure.
It took a jury eight hours to determine that damages of $550 million would fairly compensate 22 women plaintiffs for cancer-linked injuries they say they suffered from long-term use of Johnson & Johnson’s talcum powder.
Here’s a story with a California nexus that easily relates to residents in Connecticut and all other states.
No one can reasonably claim that a recent demand from the U.S. Food and Drug Administration aimed at makers of select baby teething products came unexpectedly.
Pelvic mesh implants were introduced about a generation ago. They have been widely used across the world to treat so-called “stress incontinence” in women.